Shaun Treweek

This PhD position at the University of Aberdeen is part of the EDICT (Equity, Diversity and Inclusion in Clinical Trials) Horizon Europe Marie Skłodowska-Curie Actions Doctoral Network (MSCA-DN). The network comprises seven leading European institutions, industry partners, and clinical trial networks, aiming to transform the design, conduct, and reporting of clinical trials for greater inclusivity. As one of 16 Doctoral Candidates, you will work across four interconnected work packages: Measurement, Methodologies, Implementation, and Systemic Change. The project focuses on the practical and systemic challenges of translation and interpretation in clinical trials. While translation of written materials is often seen as a way to increase inclusivity, evidence suggests that other factors, such as trust, may be more significant barriers for non-native speakers. The research aims to clarify how translation and interpretation can be effectively integrated into trial planning to support real inclusion. You will undertake four studies: (1) Evidence synthesis through systematic or scoping reviews of current translation and interpretation practices in trials, including analysis of trial registries, protocols, and published results; (2) Qualitative research with trialists, patient partners, regulators, industry representatives, and under-represented community members to explore motivations and barriers for translation/interpretation, using behavioral frameworks like COM-B/TDF; (3) Method development to define decision criteria for language support, prioritizing languages based on stakeholder input and monitoring translated/interpreted materials; (4) Creation of practical tools and guidance for trialists, with user-testing in collaboration with CIRCLE (Uppsala) and PFMD (Belgium). Secondments are planned with CIRCLE in Sweden (months 12–16) to discuss translation needs with ethnic minority individuals and leverage ongoing work in East Africa, and with PFMD in Belgium (months 22–26) to develop tools for patient engagement. Key outputs include peer-reviewed articles, conference presentations, and practical materials to guide trialists in inclusive trial design. The position offers mixed-methods training, systematic review skills, consensus-building, and tool development experience. Funding is provided through the MSCA-DN programme, including a competitive salary (£43,639 per annum), mobility allowance (£454.40/month), and potential family allowance (€660/month gross). Additional MSCA allowances may apply. Candidates must demonstrate their right to work in the UK and may be eligible for sponsorship under the Skilled Worker route. Applicants should have a relevant degree in medicine, medical sciences, public health, linguistics, or a related field. Experience with mixed-methods research, systematic reviews, and qualitative studies is desirable. For informal enquiries, contact Dr Magdalena Rzewuska Diaz at [email protected]. The application deadline is March 30, 2026. For application instructions, visit the provided link.

This PhD position at the University of Aberdeen is part of the EDICT (Equity, Diversity and Inclusion in Clinical Trials) Horizon Europe Marie Skłodowska-Curie Actions Doctoral Network (MSCA-DN). The network comprises seven leading European institutions and industry partners, aiming to transform the design, conduct, and reporting of clinical trials by advancing inclusivity. As one of 16 Doctoral Candidates, you will contribute to four interconnected work packages: Measurement, Methodologies, Implementation, and Systemic Change. The project focuses on evaluating inclusivity in clinical trials, specifically developing guidance and practical tools for the clinical trial community. You will conduct a systematic review of efforts to define inclusivity, including peer-reviewed papers, policy documents, and consensus statements. Qualitative research with stakeholders—trialists, patient partners, regulators, industry representatives, and under-represented communities—will explore perceptions and requirements for inclusive trials. Participatory workshops will further refine measurement criteria and operationalize inclusivity in trial design and reporting. The final phase involves creating and user-testing tools and guidance to support trialists in making evidence-based decisions about inclusivity. Secondments are planned at ECRIN (France) and the Dutch Cardiovascular Research Network (The Netherlands), providing exposure to international clinical trial infrastructures and regulatory perspectives, as well as specialized experience in cardiovascular research reporting. Key outputs include scientific articles, conference presentations, and practical resources for trialists. Training relevance is high, with opportunities to develop mixed-methods expertise, systematic review skills, consensus-building approaches, and tool development. The project directly contributes to improving inclusivity in clinical trials, supporting accessible, evidence-based resources for trial design and conduct. Funding is provided through the MSCA-DN programme, offering a full-time employment contract, a competitive salary (£43,639 per annum), a monthly mobility allowance (£454.40), and a family allowance (€660 per month gross) where eligible. Additional MSCA allowances may apply. Candidates must demonstrate their right to work in the UK and may be eligible for sponsorship under the Skilled Worker route. Applicants should have a strong undergraduate degree (minimum 2.1 honours or international equivalent) in health sciences, psychology, public health, implementation science, or a related field, with a strong academic record. Postgraduate study or research experience is advantageous. MSCA-DN eligibility requirements, including the mobility rule, apply. Willingness to undertake international mobility and secondments is essential. For informal enquiries, contact Professor Shaun Treweek ([email protected]). The application deadline is March 30, 2026. Please visit the application link for further details and instructions.